Scott J Weissman1, Nellie I Hansen2, Kristen Zaterka-Baxter2, Rosemary D Higgins3, Barbara J Stoll4. 1. Center for Global Infectious Disease Research, Seattle Children's Research Institute, Washington. 2. Social, Statistical and Environmental Sciences, RTI International, Research Triangle Park, North Carolina. 3. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. 4. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia Children's Healthcare of Atlanta, Georgia Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network, Bethesda, Maryland.
Abstract
BACKGROUND: Escherichia coli associated with early-onset sepsis (EOS) have historically been antibiotic-susceptible and K1-encapsulated. In the era of emerging antibiotic resistance, however, the clonal makeup of E coli associated with EOS has not been well characterized. METHODS: Escherichia coli isolates were collected from 28 cases of EOS and early-onset meningitis (EOM) from April 2008 through December 2009, during a parent study conducted at National Institute of Child Health and Human Development Neonatal Research Network centers from February 2006 through December 2009. Clinical and microbiologic data were collected for the parent study. We applied polymerase chain reaction- and sequence-based molecular techniques to determine clonal, virulence-associated and antibiotic resistance-associated traits of the E coli isolates. RESULTS: Among 28 E coli strains, phylogroup B2 strains predominated (68%), of which more than half were K1-encapsulated (53%). Phylogroup D strains were prominent as well (18%), but none were K1-encapsulated. Across the strain collection, the rate of ampicillin resistance was high (78%). The sole strain resistant to either extended-spectrum cephalosporins or fluoroquinolones represented ST131 H30-Rx, the multidrug-resistant subclone that has emerged worldwide in the last decade. This strain encoded extended-spectrum β-lactamase CTX-M-15 and carried an IncF plasmid of type F2:A1:B-. CONCLUSIONS: In this collection of EOS/EOM-associated E coli isolates, we observed a high rate of ampicillin resistance, a low rate of fluoroquinolone resistance, and no aminoglycoside resistance, with resistance to third-generation cephalosporins appearing in only a single strain, from the worldwide emerging ST131 clone. Ongoing surveillance of antibiotic resistance among EOS isolates is warranted, to ensure that standard empiric regimens remain effective.
BACKGROUND:Escherichia coli associated with early-onset sepsis (EOS) have historically been antibiotic-susceptible and K1-encapsulated. In the era of emerging antibiotic resistance, however, the clonal makeup of E coli associated with EOS has not been well characterized. METHODS:Escherichia coli isolates were collected from 28 cases of EOS and early-onset meningitis (EOM) from April 2008 through December 2009, during a parent study conducted at National Institute of Child Health and Human Development Neonatal Research Network centers from February 2006 through December 2009. Clinical and microbiologic data were collected for the parent study. We applied polymerase chain reaction- and sequence-based molecular techniques to determine clonal, virulence-associated and antibiotic resistance-associated traits of the E coli isolates. RESULTS: Among 28 E coli strains, phylogroup B2 strains predominated (68%), of which more than half were K1-encapsulated (53%). Phylogroup D strains were prominent as well (18%), but none were K1-encapsulated. Across the strain collection, the rate of ampicillin resistance was high (78%). The sole strain resistant to either extended-spectrum cephalosporins or fluoroquinolones represented ST131 H30-Rx, the multidrug-resistant subclone that has emerged worldwide in the last decade. This strain encoded extended-spectrum β-lactamase CTX-M-15 and carried an IncF plasmid of type F2:A1:B-. CONCLUSIONS: In this collection of EOS/EOM-associated E coli isolates, we observed a high rate of ampicillin resistance, a low rate of fluoroquinolone resistance, and no aminoglycoside resistance, with resistance to third-generation cephalosporins appearing in only a single strain, from the worldwide emerging ST131 clone. Ongoing surveillance of antibiotic resistance among EOS isolates is warranted, to ensure that standard empiric regimens remain effective.
Authors: Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins Journal: Pediatrics Date: 2011-04-25 Impact factor: 7.124
Authors: Timothy J Johnson; Yvonne M Wannemuehler; Sara J Johnson; Catherine M Logue; David G White; Curt Doetkott; Lisa K Nolan Journal: Appl Environ Microbiol Date: 2007-02-02 Impact factor: 4.792
Authors: Scott J Weissman; Sujay Chattopadhyay; Pavel Aprikian; Mana Obata-Yasuoka; Yuliya Yarova-Yarovaya; Ann Stapleton; William Ba-Thein; Daniel Dykhuizen; James R Johnson; Evgeni V Sokurenko Journal: Mol Microbiol Date: 2006-02 Impact factor: 3.501
Authors: Veronika Tchesnokova; Mariya Billig; Sujay Chattopadhyay; Elena Linardopoulou; Pavel Aprikian; Pacita L Roberts; Veronika Skrivankova; Brian Johnston; Alena Gileva; Irina Igusheva; Angus Toland; Kim Riddell; Peggy Rogers; Xuan Qin; Susan Butler-Wu; Brad T Cookson; Ferric C Fang; Barbara Kahl; Lance B Price; Scott J Weissman; Ajit Limaye; Delia Scholes; James R Johnson; Evgeni V Sokurenko Journal: J Clin Microbiol Date: 2013-07-10 Impact factor: 5.948
Authors: Lance B Price; James R Johnson; Maliha Aziz; Connie Clabots; Brian Johnston; Veronika Tchesnokova; Lora Nordstrom; Maria Billig; Sujay Chattopadhyay; Marc Stegger; Paal S Andersen; Talima Pearson; Kim Riddell; Peggy Rogers; Delia Scholes; Barbara Kahl; Paul Keim; Evgeni V Sokurenko Journal: mBio Date: 2013-12-17 Impact factor: 7.867
Authors: Marta Gomarasca; Thaynan F C Martins; Lilo Greune; Philip R Hardwidge; M Alexander Schmidt; Christian Rüter Journal: Antimicrob Agents Chemother Date: 2017-03-24 Impact factor: 5.191
Authors: Angela C Garinis; Alison Kemph; Anne Marie Tharpe; Joern-Hendrik Weitkamp; Cynthia McEvoy; Peter S Steyger Journal: Int J Audiol Date: 2017-06-22 Impact factor: 2.117
Authors: Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout Journal: Clin Microbiol Rev Date: 2019-06-12 Impact factor: 26.132
Authors: Dustin D Flannery; Karen M Puopolo; Nellie I Hansen; Jeffrey S Gerber; Pablo J Sánchez; Barbara J Stoll Journal: Pediatr Infect Dis J Date: 2022-03-01 Impact factor: 2.129